GlassScriptPhysician profile
Syed Shaukat
NPI 1316069883
$22,114.18
in general payments reported to CMS, 2019-2025
75 companies · $3,352 in 2025
The $3,352 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,503 · 2020: $2,606 · 2021: $3,466 · 2022: $3,562 · 2023: $2,977 · 2024: $3,649 · 2025: $3,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,977.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,208.37 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $1,656.83 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Biogen, INC. | $1,589.79 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Novartis Pharmaceuticals Corporation | $1,287.58 | 2019-2025 | |
| Lundbeck LLC | $960.92 | 2019-2025 | Vyepti, Rexulti |
| Ucb, INC. | $910.09 | 2019-2025 | Rystiggo, Briviact, Zilbrysq |
| Lilly USA, LLC | $872.84 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Emd Serono, INC. | $871.97 | 2019-2025 | Mavenclad |
| Amneal Pharmaceuticals LLC | $630.63 | 2019-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Amgen INC. | $623.86 | 2019-2025 | Repatha |
| Sunovion Pharmaceuticals INC. | $616.42 | 2019-2022 | |
| Pfizer INC. | $612.63 | 2019-2025 | |
| Eisai INC. | $520.17 | 2019-2025 | |
| Neurelis, INC. | $474.47 | 2020-2025 | Valtoco |
| Genzyme Corporation | $454.24 | 2019-2025 |
Show all 75 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Shaukat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.